Treatment Delivery for Elderly Patients with Head and Neck Cancer

Principal Investigator: Guopei Yu, M.D.

Objective: In this study, we will seek to determine the extent to which treatment has been incorporated into routine practice among Medicare recipients with head and neck cancer and to identify patients characteristics that might be associated with a high probability of non-treatment. Because some clinicians may omit certain therapy for the elderly, we will measure the use rates of any treatment as well as those of combined-modality therapy. 

The study will help to improve the quality of clinical practice for elderly with head and neck cancer. The Medicare program provides health insurance for 97% of the United States population aged 65 and older. The SEER and Medicare data have been linked to facilitate population-based studies of the medical and economic outcomes of cancer treatment. Ninety-four percent of patients in the SEER Program aged 65 or older have been successfully linked to their Medicare records. Co-Investigator is Stimson Schantz, MD.

Contact Information: Guopei Yu, M.D., (212) 979-4200

Selected Publications & Presentations:

Yu GP, Hsieh CC, Yu SZ, Wang LY, Jin TH. Green-tea consumption and reduced risk of stomach cancer, a population-based case-control study in Shanghai. Cancer Causes & Control 1995; 6-532-538. [Abstract]

Yu GP, Ostroff JS, Zhang ZF, and Schantz SP. Smoking history and cancer patient survival: a hospital cancer registry study. Cancer Detection and Prevention 1997; 21:497-509. [Abstract]

Setiawan VW, Zhang ZF, Yu GP, et al. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in Chinese population. Cancer Epidemiology Biomarker and Prevention 2000; 9(1):73-80. [Abstract]

Lu ML, Orntoft TF, Wikman F, Charytonowicz E, Rabbani F, Zhang ZF, Yu GP, Cordon-Cardo C. Impact of alterations affecting the p53 pathway in bladder cancer: impact on clinical outcome. Clinical Cancer Research 2002; 8:171-179. [Abstract]

Schantz SP, Yu GP. Head and neck incidence trends in young Americans, 1973 – 1997, with a special analysis for tongue cancer. Otolaryngology and Head and Neck Surgery 2002; 128:268-274. [Abstract]

Yu GP, Zhang ZF, Hsu TC, Spitz MR, Schantz SP. Family history of cancer mutagen sensitivity, and increased risk of head and neck cancer: Cancer Letters 1999; 146:93-101. [Abstract]

Related Information: Other Research Projects in Head and Neck Oncology




Home > Current Research > Otolaryngology > Treatment Delivery for Elderly Patients with Head and Neck Cancer